Does PALBOCICLIB Cause Deep vein thrombosis? 226 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 226 reports of Deep vein thrombosis have been filed in association with PALBOCICLIB (Ibrance). This represents 0.3% of all adverse event reports for PALBOCICLIB.
226
Reports of Deep vein thrombosis with PALBOCICLIB
0.3%
of all PALBOCICLIB reports
16
Deaths
98
Hospitalizations
How Dangerous Is Deep vein thrombosis From PALBOCICLIB?
Of the 226 reports, 16 (7.1%) resulted in death, 98 (43.4%) required hospitalization, and 14 (6.2%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 226 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which PALBOCICLIB Alternatives Have Lower Deep vein thrombosis Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID